Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma.

Roszik, Jason; Mustachio, Lisa Maria; Livingston, John A; Groisberg, Roman; Carmagnani Pestana, Roberto; Subbiah, Vivek; Conley, Anthony P

Roszik, Jason; Mustachio, Lisa Maria; Livingston, John A; Groisberg, Roman; Carmagnani Pestana, Roberto; Subbiah, Vivek; Conley, Anthony P.

Affiliation

Roszik J; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mustachio LM; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Livingston JA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Groisberg R; Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Carmagnani Pestana R; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Subbiah V; Department of Sarcoma/Melanoma Medical Oncology, Rutgers Cancer Institute of New Jersey, 195 Little Albany St., New Brunswick, NJ 08903, USA.
Conley AP; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

Cancers (Basel) ; 13(20)2021 Oct 19.

Article in En | MEDLINE | ID: mdl-34680396

Key words

TCGA; immune checkpoint; immunotherapy; mutational burden; next-generation sequencing; soft tissue sarcoma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google